Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. - Wikidata - awgldk - TriplyDB

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

http://www.wikidata.org/entity/Q34168811

about

Current status of transarterial radioembolization The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments Mental status changes postchemoembolization: the role of inflammatory response Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma Intrahepatic biloma following transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence, imaging features and management.Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)?Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients.Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis Transcatheter intraarterial therapies: rationale and overview Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.PET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model Vascular supply to the liver: a report of a rare arterial variant.Chemoembolization and radioembolization for hepatocellular carcinoma.Novel implications in the treatment of hepatocellular carcinoma.Nonsurgical treatment for localized hepatocellular carcinoma.Transcatheter Arterial Chemoembolization With Gelatin Sponge Microparticles Treated for BCLC Stage B Hepatocellular Carcinoma: A Single Center Retrospective Study.Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model.Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review.Intraarterial therapies for primary liver cancer: state of the art.Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study.(90)Y-glass microspheres for hepatic neoplasia.Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome.

P2860

Q26744307-570C812B-E91D-4376-9180-1ADEA026E839 Q26764896-002376FD-A211-4C6E-B9A3-52587BA6BA17 Q26770014-E262099A-D649-40F5-A573-64A10C07F872 Q26852174-CEF4711E-29B4-4A53-B2CD-5A0FE17B09D2 Q26996820-C984253D-605F-4C32-AF76-972486ED0FC4 Q27023616-79531498-A611-414F-823D-0CEC3A45BB39 Q28314897-08E6574F-17AA-49D9-A8C1-83C170E5DDFB Q33748348-5610641E-C9BC-4456-B720-60CF1E2D3BA0 Q34065128-AD479B71-85D3-491B-9275-B75B782502CE Q34330617-9D33C87C-AB65-448B-B47D-EA33DA2670A1 Q34681150-60CEFFE2-C75D-4C47-BCB4-7D0F8D3C1183 Q34975108-93FB069D-1B54-4150-97DE-23F6AA419021 Q35085486-45E0A6FF-A3C8-4A5A-98DC-4FE64D01291C Q35154103-AEDEA2E2-AE3C-4CCE-B5C9-A0F7F17655F9 Q35203257-A7BF1D3C-28CA-47D2-912B-E8C59E5DF7E2 Q35674315-01975B9F-9B32-4FF7-BF19-9561B2902891 Q35877902-28B742E5-9F64-4E01-A56F-45C820868B91 Q35894925-C682ECF7-50AB-46A0-B41F-5566D391DF3D Q36063276-4D882837-8EA7-4992-9E65-B308FB1B6121 Q36104314-87FDE24B-7DD1-4F47-9695-379C98795E13 Q36272834-D4E16DAF-C155-4317-9F6F-A508F4DD87C8 Q36278698-EF37918D-78DD-4773-A6C1-4EDFD5BEBD7C Q36383875-921B9FD0-E641-4A94-9BD4-AE9F13BC70AC Q36563082-C1C6E043-2CDD-41C1-AC06-D1994BED86AE Q36874720-9F7CE0CE-1F75-424B-A7E3-19B1A1B98830 Q36886453-27B0FC99-B55A-4414-8A09-5B0DD2350EA4 Q37039550-0B54324D-FB69-4B27-82F2-C9F35D24F16A Q37068157-E5269CC9-CC03-43FE-AB74-C5F9F4172D44 Q37114870-06CAE5C7-1D3B-4973-B33C-EAA569E012E9 Q37212216-B052CE1C-14FB-4B52-BCFC-EE9CEA94A9BD Q37238192-06F223E4-472F-425D-8355-AECE15A8FA61 Q37542835-554D2382-2C76-49AB-8157-444D7B972FBC Q37578521-D91ED44D-B614-473F-BE79-A24D8D379CEC Q37624162-C88BEA8F-3413-42DF-9DEC-4A3C5F9F0D86 Q37704703-6469B31D-54E4-41B2-84EA-F80E197E33B0 Q38109951-6B4A6F10-337D-49D8-A177-EBF8F3411D95 Q38149993-939637F2-F390-413B-84D5-AFE7C732D38B Q38441813-A37768C6-AE89-46C0-B572-888EC235C476 Q38465831-361CEDA2-1A3F-4BCB-B5D7-78FD1C804C94 Q38704781-C92DF3E8-794C-4C40-96DB-061BBB5416E1

P2860

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

http://www.wikidata.org/entity/Q34168811

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Chemoembolization for hepatoce ...... lysis in a 172-patient cohort.

@ast

Chemoembolization for hepatoce ...... lysis in a 172-patient cohort.

@en

Chemoembolization for hepatoce ...... lysis in a 172-patient cohort.

@nl

type

label

Chemoembolization for hepatoce ...... lysis in a 172-patient cohort.

@ast

Chemoembolization for hepatoce ...... lysis in a 172-patient cohort.

@en

Chemoembolization for hepatoce ...... lysis in a 172-patient cohort.

@nl

prefLabel

Chemoembolization for hepatoce ...... lysis in a 172-patient cohort.

@ast

Chemoembolization for hepatoce ...... lysis in a 172-patient cohort.

@en

Chemoembolization for hepatoce ...... lysis in a 172-patient cohort.

@nl

P1433

Q34168811-07FDB7EA-77AB-4347-B89A-80D5464E76FA

P1476

Q34168811-7D27A5E0-1CD6-4979-8BAD-21892306E092

P2093

Q34168811-08D4E0BB-6C19-4CA5-A2A5-EF0A5C46E656

Q34168811-10CCABF5-F57B-4026-AE6E-678616CED64B

Q34168811-1EF33488-5E6E-403E-8CB9-D9F63F83F4FD

Q34168811-2BD4A6A0-CEB4-44B3-B009-5A485F6DB1F3

Q34168811-2C83EDF9-C97B-4F5F-A91D-83AEBB30D9A3

Q34168811-2E18E537-E799-4677-B573-2075A7A5659E

Q34168811-40D31776-6D7C-46BF-88A8-133B17B62C13

Q34168811-44D369F0-6006-4E25-A8F6-B313E2EA6C23

Q34168811-46313453-1501-4449-9871-27851143EB02

Q34168811-4787D320-6F35-4387-8697-650C9838AC37

P2860

Q34168811-01D50E83-F076-4DEF-B4DB-32B87B6A27FD

Q34168811-0B951BA6-6885-4FEE-B513-6D5334DAB176

Q34168811-0CC6A30F-4FB9-4157-9310-8A93EBDD24DA

Q34168811-2143F056-FBF7-4480-9ADE-66998070E2AC

Q34168811-29ED499A-A31D-4FEE-A93B-986D992491A5

Q34168811-2E75CCB7-2E07-4994-8F7C-A6E324A3CE9F

Q34168811-33D8A230-F826-4842-8756-320FB55CF4F3

Q34168811-3A11D1DC-6757-4E96-9846-803EA13FA8D8

Q34168811-4AE6B3E0-5428-4423-B491-570710BD174B

Q34168811-5B45F0DA-7F00-4387-A349-889D9245278D

P304

Q34168811-B42D9D81-7D17-4DE3-B050-9F0073A16B9F

P31

Q34168811-EEC6A652-588A-4A57-AEC2-B82D8B7A1636

P356

Q34168811-7CC00928-3F50-4A98-80DF-0BB4489764F2

P407

Q34168811-AA4153BB-EFFD-42E2-955E-1ED16D9F6C0E

P433

Q34168811-FFBEC592-3977-4CD0-98E1-973DC2417697

P478

Q34168811-E559246F-00A5-4293-BA81-D0CDA3E3B305

P50

Q34168811-1DC7323A-8466-4496-A618-B76AB206897D

Q34168811-D75F8AB0-6427-4EAA-88F1-2F62BB458A5C

P577

Q34168811-800960C0-3B61-4831-8A91-23CB0C8EDC90

P5875

Q34168811-F820A305-350F-44A0-A4BC-DEF418AFE514

P698

Q34168811-C66AC726-9D20-49A4-A879-E13FBD03703E

P921

Q34168811-3F68932F-E222-421C-AF93-7B9D2BF51C06

P932

Q34168811-779B9076-B7FA-46B8-ADDC-AF0C1FBB5263

P356

RADIOL.10091473

P1433

P1476

Chemoembolization for hepatoce ...... alysis in a 172-patient cohort

@en

P2093

Al B Benson

http://www.w3.org/2001/XMLSchema#string

Albert A Nemcek

http://www.w3.org/2001/XMLSchema#string

Edward Wang

http://www.w3.org/2001/XMLSchema#string

Frank H Miller

http://www.w3.org/2001/XMLSchema#string

Howard B Chrisman

http://www.w3.org/2001/XMLSchema#string

Kent T Sato

http://www.w3.org/2001/XMLSchema#string

Laura M Kulik

http://www.w3.org/2001/XMLSchema#string

Mary F Mulcahy

http://www.w3.org/2001/XMLSchema#string

Michael I Abecassis

http://www.w3.org/2001/XMLSchema#string

Ramona Gupta

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Sorafenib in advanced hepatocellular carcinoma

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Primary liver cancer: worldwide incidence and trends

Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.

P304

955-965

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.10091473

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

255

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44629633

http://www.w3.org/2001/XMLSchema#string

P698

20501733

http://www.w3.org/2001/XMLSchema#string

P921

P932

2948657

http://www.w3.org/2001/XMLSchema#string